Skip to main content
Erschienen in: Knee Surgery, Sports Traumatology, Arthroscopy 8/2023

Open Access 16.04.2023 | ANKLE

Non-operative management for osteochondral lesions of the talus: a systematic review of treatment modalities, clinical- and radiological outcomes

verfasst von: Tristan M. F. Buck, Kenny Lauf, Jari Dahmen, J. Nienke Altink, Sjoerd A. S. Stufkens, Gino M. M. J. Kerkhoffs

Erschienen in: Knee Surgery, Sports Traumatology, Arthroscopy | Ausgabe 8/2023

Abstract

Purpose

The purpose of the present study was to assess the overall clinical success rate of non-operative management for osteochondral lesions of the talus (OLT).

Methods

A literature search was conducted in the PubMed (MEDLINE), COCHRANE and EMBASE (Ovid) databases. Clinical success rates per separate study were calculated at the latest moment of follow-up and were defined as successful when a good or excellent clinical result at follow-up was reported in a qualitative manner or when a post-operative American Orthopaedic Foot and Ankle Society (AOFAS) score at or above 80 was reached. When clinical outcomes were based on other clinical scoring systems, outcomes reported as good or excellent were considered as clinical success. Studies methodologically eligible for a simplified pooling method were combined to calculate an overall pooled clinical success rate. Radiological changes over the course of conservative treatment were assessed either considering local OLT changes and/or overall ankle joint changes.

Results

Thirty articles were included, including an overall of 868 patients. The median follow-up of the included studies was 37 months (range: 3–288 months). A simplified pooling method was possible among 16 studies and yielded an overall pooled clinical success rate of 45% (95% CI 40–50%). As assessed with plain radiographs, progression of ankle joint osteoarthritis was observed in of 9% (95% CI 6–14%) of the patients. As assessed through a Computed Tomography (CT) scan, focal OLT deterioration was observed in 11% (95% CI 7–18%) of the patients. As assessed with a Magnetic Resonance Imaging (MRI) scan, focal OLT deterioration was observed in 12% (95% CI 6–24%) of the patients. An unchanged lesion was detected on plain radiographs in 53% (48/91; CI 43–63%), 76% (99/131; 95% CI 68–82%) on a CT scan and on MRI in 84% (42/50; 95% CI 71–92%) of the patients.

Conclusion

The current literature on non-operative management of OLTs is scarce and heterogeneous on indication and type of treatment. Promising clinical results are presented but need to interpreted with caution due to the heterogeneity in indication, duration and type of treatment. Further studies need to focus on specific types on conservative management, indications and its results.

Level of evidence

Systematic review, Level IV.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00167-023-07408-w.
Tristan M. F. Buck and Kenny Lauf have contributed equally to this work and thus share first authorship.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Osteochondral lesions of the talus (OLTs) are focal problems of the cartilage and its subchondral bone [10, 25]. The first treatment in line for the specific injury is a non-operative protocol potentially consisting of different types of subtypes of non-operative treatment options [12]. A surgical intervention can be needed in case of persistent and restrictive complaints after at least 6 months of non-operative treatment protocol.
To date, the most comprehensive study concerning non-operative treatment available is a systematic review from Zengerink et al. [44]. Despite the clear oversight of outcomes, this study included articles published up to the year of 2006 and an update of outcomes will add value to daily practice. Furthermore, radiological outcomes were not assessed and further sub-specify the clinical efficacy of the different subtypes of non-operative treatment protocols beyond rest and casting.
Consequently, it is currently unclear how effective non-operative therapy is for osteochondral lesions of the talus (OLTs) and which sub-type of non-operative therapy is most effective. It is therefore the purpose of the this study to assess the overall clinical success rate and associated radiological progress of focal or generalized joint degenerative changes after non-operative management for OLTs and to analyze different subtypes of non-operative management if possible. Our secondary hypothesis is that non-operative management yields an overall successful clinical result in approximately half of the patients.

Materials and methods

This review was performed according to the PRISMA guidelines and was prospectively registered in the Prospero database with registration number CRD42018114667 [9].

Search strategy

An electronic literature search was performed—the specific search strategy is presented in Appendix 1. After the first search, title and abstracts were screened for eligibility based on the inclusion- and exclusion criteria (Table 1).
Table 1
Inclusion- and exclusion criteria
Inclusion criteria
Exclusion criteria
All studies reporting clinical or radiological outcomes of any type of non-operative management option for symptomatic talar OLTs
Presence of other lower extremity diagnoses other than talar OLT and associated OLT injuries
Primary and non-primary OLTs
 < 5 patients included in the study
Level 1–4 studies
Level 5 evidence
Published in a peer-reviewed journal
Studies with overlapping patient groups
Full-text available in English
 

Eligibility criteria and study selection

All studies including title and abstract were independently screened by two independent researchers (JD, KL). When there was no agreement, assessment by an independent third investigator (GK) would be decisive for inclusion or exclusion. Subsequently, full text articles of the initial included studies were viewed for eligibility based on the same in- and exclusion criteria. Again, in case of any conflict, a third author (GK) was consulted for the final decision. The exact inclusion and exclusion criteria are presented in Table 1. No restrictions on age of the included patients were applied.

Quality assessment

Risk of Bias and quality of the included articles was assessed by two reviewers (TB and JD) with the use of the Methodological Index for Non-Randomized Studies (MINORS) criteria [37]. Each included study was graded by 2 independent reviewers (JD, TB). When there was no agreement, assessment by a third independent investigator (GK) would be decisive.

Data extraction and pooling

Two reviewers independently collected and cross-checked all the data (KL, TB). The following study characteristics data were collected: authors, title, type of study, level of evidence of study, year of publication, clinical scoring systems used, treatment type applied, indications for non-operative treatment, mean and range of follow-up time. Patient data extracted from the studies included number of patients, mean age, sex, number of ankles, number of patients who converted to surgery including the rate of conversion to surgery, duration of symptoms, clinical outcomes, radiological outcomes and reported success of treatment. In case of several follow-up reports, the latest report is extracted.

Statistical and data analysis

Clinical outcomes were defined as successful when a good or excellent clinical result at follow-up was reported in a qualitative manner or when at the latest follow-up of a post-operative American Orthopaedic Foot and Ankle Society (AOFAS) score at or above 80 was reached [19]. When clinical outcomes were based on other clinical scoring systems, outcomes reported as good or excellent were considered as clinical success. Subsequently, clinical success rates were calculated per study. A simplified pooling method was used to combine data from different studies using corresponding methodologies to provide clinical success rate results for the overall non-operative treatment group and to provide separate pooled results for the clinical success rates of different subtypes of non-operative treatment options. Ninety-five percent binomial proportion confidence intervals for the success percentages of each study and the pooled studies will be calculated with the Wilson score interval [5]. Radiological changes over the course of conservative treatment were assessed either considering local OLT changes and/or overall ankle joint changes. Pooling of radiological results was exclusively performed whenever the same radiological method was used (i.e., computed tomography, magnetic resonance imaging, and plain radiographs). Whenever possible, pooled rates including 95% confidence intervals were calculated for the following outcomes: rate of unchanged radiological presentation, rate of radiological progression of the lesion, and rate of healing of the lesion.

Results

Search results

The initial search yielded a total of 1824 articles. After the screening of title and abstract, a total of 1625 articles were excluded based on the in- and exclusion criteria. Finally, a total of 30 articles were included (Fig. 1). There were no conflicts during the process. The years of publication of the included studies are summarized in Fig. 2. Twenty-seven studies were retrospective series and only 3 studies had a prospective data registration. All general, clinical and radiological data are presented in Appendix 1.

Characteristics of included studies

Thirteen articles reported on only (initial) non-operatively treated patients. Seventeen articles reported on both non-operative and surgical management. The total number of initially non-operatively treated patients in the included studies was 868. The median follow-up of the included studies was 37 months, ranging from 3 to 288. The mean age was 33.8 (9.0–56.08). For 626 patients for whom gender was reported, 336 were male and 290 were female. Side of the lesion was reported for 523 lesions, 332 were right sided and 191 were left sided. Location of the lesion on the talus was reported for 592 lesions, 478 lesions were medial, 107 lateral and 7 central on the talus. Only 14 patients, distributed over 3 studies, had non-primary lesions, and no separate outcomes were reported on these patients [23, 27, 28].
Seven articles reported on a post-treatment Visual Analogue Scale (VAS) [8] pain score, with a mean ranging from 0–5.4 [1, 18, 23, 28, 35]. Measuring the treatment effect with the AOFAS score was used in eleven studies with a post-treatment score ranging from 68.2 to 98 [1, 15, 18, 20, 21, 23, 27, 28, 32, 35, 42]. An overview of all study characteristics, clinical and radiological outcomes is presented in Appendix 2.

Methodological quality

After independent grading and discussion by 2 reviewers (JD, TB), full consensus on methodological quality was reached. The results of the MINORS score for the included studies are presented in Appendix 2.

Indications

The indications for non-operative treatment were mentioned in 40% (12/30) of the included studies. Stage 1 or 2 lesions according to the Berndt and Harty classification [17], stage 1, 2 or 3 lesions [1, 7], stage 1, 2, 3 or 4 lesions [30], stage 5 lesions [36], asymptomatic or minimally symptomatic lesions [20, 34, 45], failure of other primary non-operative strategies [23, 28], or minimal activity on SPECT/CT-scans [27]. Additionally, one study reported the lack of justification of surgery for the intensity of symptoms [31].

Clinical outcomes

The overall pooled success rate was 45% (168/372; 95%CI 40–50%). Conversion to surgery after initial non-operative management was described in 11 studies yielding a total pooled conversion to surgery rate of 46% (184/400; 95%CI 41–51%). The pooled clinical outcomes are presented in Table 2. If the provided data in selected articles do not include information for conservatively treated patients separately, information is not presented in this table.
Table 2
Clinical outcomes
Subtype of treatment
Study
Follow-up time (months, range)
Clinical success rate
Conversion to surgery
Description success
Adjustment of activities
Seo et al. [35]
72 (36–120)
NA
11% (5/56; 95%CI 5–21%)
 
Heyse et al. [15]
NA (NA)
NA
60% (45/75; 95%CI 49–70%)
 
Weightbearing restrictions
Flick and Gould [13]
NA (NA)
0% (0/8; 95%CI 0–32%)
63% (5/8; 95%CI 31–68%)
“Excellent”, “Good”, “Fair”, “Poor” based on a self-developed questionnaire
Huylebroek et al. [17]
NA (NA)
55% (12/22; 95%CI 35–73%)
NA
“Good”: No pain, able to perform all activities or the same level of sports
Ibanez et al.[18]
NA (NA)
NA
NA
 
Meftah et al. [27]
36 (NA)
NA
NA
 
Injectables
Akpancar and Gül [1]
12 (NA)
90% (44/49; 95%CI 78–96%)
NA
“Excellent”: If there was no ankle pain after daily activities or sport activities
“Good”: Pain levels <50% of the original ankle pain
 PRP OR Prolotherapy
 99mTc-MDP
Liu et al. [23]
7 (6–15)
NA
NA
 
 Hyaluronate
Gesu et al. [24]
3 (NA)
NA
NA
 
 PRP OR Hyaluronate
Mei-Dan et al. [28]
7 (NA)
NA
NA
 
Other
Berndt et al. [3]
NA (NA)
10% (2/21; 95%CI 3–29%)
67% (14/21; 95%CI: 45–83%)
“Good”: Freedom of symptoms or if only slightly annoying.
Davidson et al. [11]
20 (0.5–100)
18% (3/17; 95%CI 6–41%)
53% (9/17; 95%CI 31–74%)
Literally mentioned “Good” or “Very good”
Blom and Strijk [4]
NA (NA)
20% (9/44; 95%CI 11–35%)
30% (13/44; 95%CI 18–44%)
“Good”: Entirely or almost entirely free from symptoms
McCullough and Venugopal [26]
NA (NA)
83% (5/6; 95%CI 44–97%)
NA
“Excellent”: No symptoms related to ankle
“Good”: Occasional ankle discomfort that does not limit normal activity
Thompson and Loomer [40]
NA (NA)
0% (0/3; 95%CI 0–56%)
NA
“Good”: No pain, no activity restrictions,normal physical exam and a normal plain radiograph
Pettinne and Morrey [30]
NA (NA)
46% (17/37; 95%CI 31–62%)
NA
“Good”: Asymptomatic
Zinman et al. [45]
NA (NA)
13% (4/31; 95%CI 5–29%)
71% (22/31; 95%CI 53–84%)
“Excellent”: Returned to regular activity and no limitation or pain while running or walking
“Good”: Not limited in walking, but who had occasional pain
Wester et al. [43]
288 (84–432)
NA
NA
 
Higuera et al. [16]
NA (NA)
NA
9% (1/11; 95%CI 2–38%)
 
Shearer et al. [36]
38 (17–85)
54% (19/35; 95%CI 38–70%)
17% (6/35; 95%CI 8–33%)
“Excellent”: Symptoms are gone or greatly improved and no sport limitations
“Good”:
1) Symptoms are gone or greatly improved and some limitations in sports or
2) Slightly improved symptoms and no sport limitations
Letts et al. [22]
NA (NA)
38% (9/24; 95%CI 21–57%)
54% (13/24; 95%CI 35–72%)
“Good”: Occasional symptoms without loss of function
Perumal et al. [29]
12 (NA)
16% (5/31; 95%CI 7–33%)
39% (12/31; 95%CI 24–56%)
Complete clinical and radiological healing
Lam et al. [21]
30.5 (11–63)
100% (6/6; 95%CI 61–100%)
NA
“Excellent” or “Good” based on the Higuera classification
Reilingh et al. [33]
NA (NA)
NA
92% (34/37; 95%CI 79–97%)
 
Rehnitz et al. [32]
NA (NA)
69% (11/16; 95%CI 44–86%)
NA
AOFAS > 80
Weigelt et al. [42]
168 (132–240)
100% (22/22; 95%CI 85–100%)
NA
Good or excellent on the AOFAS score
 
Pooled result
 
45% (168/372; 95%CI 40–50%)
46% (184/400; 95%CI 41–51%)
 
Methylene Diphosphonate
AOFAS American Orthopedic Foot and Ankle Outcome Score, NA Not Available, 99mTc-MDP: Technetium-99 m

Radiological outcomes

Plain radiographs radiological outcomes

Definitions of healing on plain radiographs being used in the included studies were decrease in size of the lesion (width, depth or length) or the description of any signs of decrease in the lesion size. Definitions of unchanged lesions being used in the included studies were unchanged lesions, no signs of ossification, unhealed lesions or still visible lesions. The use of a plain radiograph to assess the radiological changes of the lesion was described in 5 articles [21, 26, 29, 34, 43]. As assessed with a plain radiograph, radiological deterioration was observed in 84% (76/91; 95%CI 75–90%) of the patients. More specifically, the pooled healing rate was 31% (28/91; 95%CI 22–41%). An unchanged lesion was detected on plain radiographs in 53% (48/91; CI 43–63%) of the patients, and a progression of the defect was seen in 23% (21/91; 95%CI 16–33%) of the patients. Osteoarthritic changes, i.e., overall ankle joint changes, as assessed with plain radiographs were reported in 5 studies [20, 26, 35, 36, 42]. Pooling of patients with progression of osteoarthritis of the ankle showed a rate of 9% (185/204; 95%CI 6–14%) as assessed with the van Dijk osteoarthritis scale [41].

Computed tomography radiological outcomes

The use of a CT scan to assess radiological outcomes was described in 4 articles [23, 35, 36, 43]. Healing of lesions on CT scans were described if a decrease in size (width, depth or length) was observed or if CT scans were rated as ‘’normal radiological findings’’. Radiological outcomes based on a Computed Tomography (CT) scan were described in 4 studies. No radiological deterioration was observed in 89% (116/131; 95%CI 82–93%) of the patients. More specifically, the pooled healing rate was 13% (17/131; 95%CI 8–20%) [23, 35, 36, 43], the unchanged radiological rate was 76% (99/131; 95%CI 68–82%) of the patients, and progression of the defect was observed in 11% (15/131; 95%CI 7–18%) of the patients.

MRI radiological outcomes

Changes on MRI were observed in case of change in stage on the Andersen Scale. The use of an MRI scan to assess radiological outcomes was described in 1 article [20]. No radiological deterioration of the lesion was observed in 88% (44/50; 95%CI 76–94%) of the patients. Healing was observed in 4% (2/50; 95%CI 1–13%) of the patients, no change of the lesion was observed in 84% (42/50; 95%CI 71–92%) of the patients, and a progression of the lesion was observed in 12% (6/50; 95%CI 6–24%) of the patients [20].

Types of non-operative treatment

Adjustment of activities

Solely adjustment of activities, also called a “benign neglect” was described in two studies including a total number of 357 patients of which 218 patients were treated with activity adjustment [15, 35]. Success rates were not reported in this subgroup. A total of 39% (51/131; 95%CI 31–47%) of the patients were converted to surgery. Seo et al. [35] described a mean pre-treatment VAS pain of 3.8 and a mean post-treatment VAS pain of 0.9 of 142 patients that were treated with activity adjustment. Heyse et al. [15] reported a mean post-treatment AOFAS ankle hindfoot score of 68.2 and an Olerud/Molander score of 90.6 in 30 patients. Only Seo et al. [35] reported radiological outcomes with healing of the lesion in 6% (5/83; 95%CI 3–13%), unchanged lesion in 83% (69/83; 95%CI 74–90%) and progression of the lesion in 11% (9/83; 95%CI 6–19%). Additionally, 0% (0/0; 95%CI 0–3%) showed progression of osteoarthritis.

Weight bearing restrictions

Solely weight bearing restrictions or in combination with a cast was applied in 4 studies including a total of 51 patients [13, 17, 18, 27]. The time of cast immobilization ranged between 3 and 8 weeks. The pooled success rate in this group was 55% (12/22; 95%CI 34–73%). The calculated rate of conversion to surgery was 63% (5/8; 95%CI 31–86%).
Ibanez et al. [18] reported a mean pre-treatment AOFAS ankle hindfoot score of 58 and a mean post-treatment score of 74.8. The mean VAS score in this study improved from 9 to 5.4. Meftah et al. [27] reported a mean AOFAS post-treatment score of 87.3. Lam et al. [21] reported a mean post-treatment AOFAS hindfoot score of 90. None of the studies in this subgroup reported on radiological outcomes.

Injectables

Solely Injectables were applied in four articles and included the following types: Platelet Rich Plasma (PRP), HA, sodium hyaluronate, prolotherapy and TC-methylene diphosphonate with herbal fumigation [1, 23, 24, 28]. The total number of patients was 175 and the median time of follow-up was 5 months. One study reported success rate of 90% (44/49; 95%CI 78–96%) [1]. Conversion to surgery was not reported in any of the selected studies in this group. The number of injections and time intervals are described in Appendix 2. Mei-Dan et al. [28] reported an improvement on the VAS (pain) scale from 5.6 to 3.1 in the HA group and from 4.1 to 0.9 in the PRP group. The AOFAS improved from 66.4 to 78.3 in the HA group and from 68 to 92.5 in the PRP group. Liu et al. [23] reported an improvement from 3.05 to 1.85 on the VAS (pain) scale and from 68.66 to 85.40 on the AOFAS score. Gesu et al. [24] reported an improvement from 52 to 98 on the AOFAS scale.
Akpancar and Gül [1] reported an improvement on the VAS pain scale from 7.15 to 1.30 in the prolotherapy group and from 7.73 to 1.41 in the PRP group. AOFAS improved from 38.48 to 89.44 in the prolotherapy group and 30.09 to 87.77 in the PRP group.
Only Liu et al. [23] reported on radiological outcomes and observed a decrease in cyst average from 8.1 to 4.7 mm in diameter.

Other

Shearer et al. [36], Berndt et al. [3] and Pettine et al. [30] reported on different types of non-operative management in one study without reporting results on each subgroup. Non-operative management in these studies includes weight bearing restrictions, use of NSAIDs, physiotherapy, casts and braces.
Combination of non-operative modalities were reported in five studies and were as follows: restricted sports activities and physical therapy, taping or treatment with a plaster cast, cast immobilization and restrictions of activities, cast immobilization and protected weight bearing, cast immobilization and activity modification, activity restriction and physical therapy [21, 22, 27, 29, 33]. Eight articles described the use of a brace or strapping [3, 13, 2931, 33, 36, 43]. One article described the use of shockwave therapy as non-operative management [39].

Discussion

The most important finding of the present study is that non-operative treatment for osteochondral lesions of the talus is clinically effective in 45% of the patients. No evidence was identified that one of the subtypes of non-operative management protocols were superior or inferior to one another from a clinical or radiological perspective.
It is to be stated that non-operative treatment is recommended as first treatment in line after the initial diagnosis of an OLT as a result of our findings [12]. The used strategies in non-operative treatment were heterogeneous as they differed widely in the included articles. Four articles used a so called “benign neglect’’ or modification of the activities [15, 35, 36, 40]. Seo et al. [35] stated that good clinical results were obtained with a mean AOFAS of 93 points at a long-term follow-up. Another interesting finding from the study of Seo et al. [35] was that the average VAS score of pain at baseline was 3.8, suggesting that patients did not have major complaints at the onset of treatment. Despite that a lower level of complaints might be an indication for the choice of non-operative treatment, other indications were not mentioned in any of the studies reporting on solely activity restrictions or a “benign neglect’’.
Weightbearing restrictive treatment modalities were also frequently reported non-operative treatment options as four studies were included in our systematic review on this particular treatment modality [13, 17, 18, 27]. Periods of immobilization in the included studies ranged from 3 to 8 weeks. It was found that the success rates having been found in the studies on immobilization were around 50% [17, 30]. There was no superiority observed concerning clinical outcomes with longer immobilization periods. Despite this promising result, no radiological results can demonstrate improvement of the lesion due to immobilization.
Two articles described the use of injectables by injecting hyaluronic acid or 99 m TC-methylene diphosphonate. Liu et al. [23] noticed substantial clinical progression in terms of the AOFAS and VAS scores after injection of TC-methylene diphosphonate with herbal fumigation. However, this intervention is totally new and the literature on this topic is scarce which made it impossible to draw conclusions on the working mechanism and potential effect of this treatment strategy. Hyaluronic acid injections showed its potential in improving the clinical symptoms. This may be due to the chondroprotective and anti-inflammatory effect which limiting degenerative changes coming along with the osteochondral defect [38]. Another injectable that was studied was Platelet Rich Plasma [1, 28]. These injections showed considerable improvements when considering the pain scores as measured with the VAS scale. However, it should be mentioned that these studies were conducted in small populations including relatively low number of patients. Moreover, the reported results were assessed at short-term follow-up. As such, one could state that specific conclusions considering the efficacy of injection therapy cannot be made due to the low level of evidence originating from these studies.
One can state that the methodological quality of injection therapies for OLTs was considered low, and the potential and indications of injection therapies as part of non-operative treatment for OLTs need to be further investigated in future double-blind placebo-controlled prospectively randomized studies.
In addition to different types of non-operative management, duration of the non-operative management is an important factor to analyze. Activity restrictions or cast immobilization were applied for a period ranging from 3 to 8 weeks. After a period of activity restriction, casting, physiotherapy or a combination of all, patients and clinicians must decide whether non-operative management meets their expectations of the treatment or if surgical treatment is indicated. The current literature suggests considering surgical management after trying non-operative management for at least 6 months. This is corresponding with literature included in this study [12]. Additionally, the literature concerning osteochondral lesions of the knee suggests that lesions can heal within a time of six months which seems to confirm that 6 months is a proper duration [2].
The conversion to surgery rate emphasizes that a certain part of the population has no indication for direct surgical treatment. However, based on the results on this review, it is difficult to define clear indications for non-operative management. Described indications varied widely in the included studies in terms of lesion characteristics and level of complains. It was therefore not possible to analyze if specific indications were superior to others. One of the indications that need to be discussed is the justification of a surgical treatment. In several studies it is stated that patients avoided surgery or that they stated that their symptoms simply did not justify their complaints [17]. This reveals that the decision-making process for non-operative management is highly important in a patient group who can accept a lower functional status with minor complains [12]. Based on the statement of Dobrowski et al. [12] and the results of present review non-operative management is advocated for at least 6 months which can be extended based on a shared-decision-making process and regular clinical and radiological follow-ups.
Concerning the radiological outcomes which were analyzed in the present study, one can note that radiological healing was assessed in the studies of Perumal et al. [29] and Wester et al. [43] having shown a healing rate of 18% and 69%, respectively. This healing rate can be considered relatively high compared to other studies [34, 36]. These healing rates can be explained by the fact that Perumal et al. [29] and Wester et al. [43] included patients from a pediatric population as it is known that patients with open growth plates have a higher healing potential [6, 14]. However, it remains unclear to what extent precisely a casting and weight bearing restriction protocol may support this healing.
It should, however, also be noted that a selective group of 10% developed arthritic changes in a relatively short period. This must aware clinicians in the risk of possible deterioration when starting conservative management. It is therefore highly recommended to have an intensive follow-up including CT-scans and physical examinations after the start of conservative management to change the treatment path and avoid irreversible damage. To identify patients benefitting from non-operative management, prospective studies on different non-operative treatment modalities are needed. These studies need to include radiological follow-up too as it enables caretakers and patients to see which impact non-operative management has on the radiological characteristics of the lesion.
Despite the discrepancy between the healing rate and the pooled success rate of non-operative treatment, it must be emphasized that the majority of the lesions do not progress over time from a radiological perspective nor showed development of osteoarthritis. The latter is an important fact in the provision of information to patients to manage their expectations.
This review has a number of strengths. First, this review was pre-registered in the PROSPERO database [9]. It must also be stated that the thorough reference selection and quality assessment of the included studies can be considered strengths of the study. Moreover, to the best of our knowledge, this is the first review summarizing different types of non-operative management including its clinical and radiological outcomes. As such, the clinical relevance of the present study entails that the summary of a comprehensive overview of the different types of non-operative treatment modalities including their clinical- and radiological outcomes will aid and improve the decision-making process.
Besides its strengths, there were a number of limitations concerning the present review. The included studies were mostly retrospective in nature and published before 1990 causing a high heterogeneity among the studies in terms of success definition, included population, follow-up moments and indications. Due to this heterogeneity, results need to be interpreted with caution as there is a high chance of indication bias. One of the heterogeneous factors was the difference in the use of clinical outcomes. Clinical success was defined as good or excellent outcomes, or an AOFAS score > 80. However, “good’’ or “excellent’’ outcomes leaves space for interpretation. The following criteria were used in the included studies to classify the outcome of the treatment: conversion to surgery, Higuera classification [16], clinical symptoms such as pain and functional results such as activity restrictions. It can be logically argued that such a wide range of definitions may lead to bias of the results. Secondly, different patient selections took place for the indication of conservative management introducing a potential selection bias. Additionally, it was found that 2% of the lesions were of non-primary (i.e., secondary or tertiary) nature, and, as, such, it is not expected that this may influence the outcomes of the present study.

Conclusion

Non-operative management for osteochondral lesions of the talus yielded an overall clinical success rate of 45%. Radiological outcomes showed that 11% of the patients deteriorate over time considering whole ankle joint osteoarthritic changes and considering focal radiological deterioration to the OLT. No evidence was found that one of the subtypes of non-operative management protocols were superior or inferior to one another.

Acknowledgements

The authors would like to thank the AMC clinical librarian, F.S. van Etten-Jamaludin, for setting up the electronic literature search used in this systematic review.

Declarations

Conflict of interest

The authors do not report any form of conflict of interest related to this research.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Orthopädie & Unfallchirurgie

Kombi-Abonnement

Mit e.Med Orthopädie & Unfallchirurgie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Akpancar S, Gul D (2019) Comparison of platelet rich plasma and prolotherapy in the management of osteochondral lesions of the talus: a retrospective cohort study. Med Sci Monit 25:5640–5647PubMedPubMedCentralCrossRef Akpancar S, Gul D (2019) Comparison of platelet rich plasma and prolotherapy in the management of osteochondral lesions of the talus: a retrospective cohort study. Med Sci Monit 25:5640–5647PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Andriolo L, Candrian C, Papio T, Cavicchioli A, Perdisa F, Filardo G (2019) Osteochondritis dissecans of the knee—conservative treatment strategies: a systematic review. Cartilage 10:267–277PubMedCrossRef Andriolo L, Candrian C, Papio T, Cavicchioli A, Perdisa F, Filardo G (2019) Osteochondritis dissecans of the knee—conservative treatment strategies: a systematic review. Cartilage 10:267–277PubMedCrossRef
3.
Zurück zum Zitat Berndt AL, Harty M (1959) Transchondral fractures (osteochondritis dissecans) of the talus. J Bone Joint Surg Am 41-A:988–1020PubMedCrossRef Berndt AL, Harty M (1959) Transchondral fractures (osteochondritis dissecans) of the talus. J Bone Joint Surg Am 41-A:988–1020PubMedCrossRef
4.
Zurück zum Zitat Blom JM, Strijk SP (1975) Lesions of the trochlea tali. Osteochondral fractures and osteochondritis dissecans of the trochlea tali. Radiol Clin 44:387–396 Blom JM, Strijk SP (1975) Lesions of the trochlea tali. Osteochondral fractures and osteochondritis dissecans of the trochlea tali. Radiol Clin 44:387–396
5.
Zurück zum Zitat Brown LD, Cai TT, DasGupta A (2001) Interval estimation for a binomial proportion. Stat Sci 16(101–133):133 Brown LD, Cai TT, DasGupta A (2001) Interval estimation for a binomial proportion. Stat Sci 16(101–133):133
6.
Zurück zum Zitat Cahill BR, Phillips MR, Navarro R (1989) The results of conservative management of juvenile osteochondritis dissecans using joint scintigraphy. A prospective study. Am J Sports Med 17:601–605 (discussion 605-606)PubMedCrossRef Cahill BR, Phillips MR, Navarro R (1989) The results of conservative management of juvenile osteochondritis dissecans using joint scintigraphy. A prospective study. Am J Sports Med 17:601–605 (discussion 605-606)PubMedCrossRef
7.
Zurück zum Zitat Canale ST, Belding RH (1980) Osteochondral lesions of the talus. J Bone Joint Surg Am 62:97–102PubMedCrossRef Canale ST, Belding RH (1980) Osteochondral lesions of the talus. J Bone Joint Surg Am 62:97–102PubMedCrossRef
8.
Zurück zum Zitat Carlsson AM (1983) Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 16:87–101PubMedCrossRef Carlsson AM (1983) Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 16:87–101PubMedCrossRef
9.
Zurück zum Zitat Chien PF, Khan KS, Siassakos D (2012) Registration of systematic reviews: PROSPERO. BJOG 119:903–905PubMedCrossRef Chien PF, Khan KS, Siassakos D (2012) Registration of systematic reviews: PROSPERO. BJOG 119:903–905PubMedCrossRef
10.
Zurück zum Zitat Dahmen J, Karlsson J, Stufkens SAS, Kerkhoffs G (2021) The ankle cartilage cascade: incremental cartilage damage in the ankle joint. Knee Surg Sports Traumatol Arthrosc 29:3503–3507PubMedPubMedCentralCrossRef Dahmen J, Karlsson J, Stufkens SAS, Kerkhoffs G (2021) The ankle cartilage cascade: incremental cartilage damage in the ankle joint. Knee Surg Sports Traumatol Arthrosc 29:3503–3507PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Davidson AM, Steele HD, MacKenzie DA, Penny JA (1967) A review of twenty-one cases of transchondral fracture of the talus. J Trauma 7:378–415PubMedCrossRef Davidson AM, Steele HD, MacKenzie DA, Penny JA (1967) A review of twenty-one cases of transchondral fracture of the talus. J Trauma 7:378–415PubMedCrossRef
12.
Zurück zum Zitat Dombrowski ME, Yasui Y, Murawski CD, Fortier LA, Giza E, Haleem AM et al (2018) Conservative management and biological treatment strategies: proceedings of the international consensus meeting on cartilage repair of the ankle. Foot Ankle Int 39:9–15CrossRef Dombrowski ME, Yasui Y, Murawski CD, Fortier LA, Giza E, Haleem AM et al (2018) Conservative management and biological treatment strategies: proceedings of the international consensus meeting on cartilage repair of the ankle. Foot Ankle Int 39:9–15CrossRef
13.
Zurück zum Zitat Flick AB, Gould N (1985) Osteochondritis dissecans of the talus (transchondral fractures of the talus): review of the literature and new surgical approach for medial dome lesions. Foot Ankle 5:165–185PubMedCrossRef Flick AB, Gould N (1985) Osteochondritis dissecans of the talus (transchondral fractures of the talus): review of the literature and new surgical approach for medial dome lesions. Foot Ankle 5:165–185PubMedCrossRef
15.
Zurück zum Zitat Heyse TJ, Schuttler KF, Schweitzer A, Timmesfeld N, Efe T, Paletta JR et al (2015) Juvenile osteochondritis dissecans of the talus: predictors of conservative treatment failure. Arch Orthop Trauma Surg 135:1337–1341PubMedCrossRef Heyse TJ, Schuttler KF, Schweitzer A, Timmesfeld N, Efe T, Paletta JR et al (2015) Juvenile osteochondritis dissecans of the talus: predictors of conservative treatment failure. Arch Orthop Trauma Surg 135:1337–1341PubMedCrossRef
16.
Zurück zum Zitat Higuera J, Laguna R, Peral M, Aranda E, Soleto J (1998) Osteochondritis dissecans of the talus during childhood and adolescence. J Pediatr Orthop 18:328–332PubMedCrossRef Higuera J, Laguna R, Peral M, Aranda E, Soleto J (1998) Osteochondritis dissecans of the talus during childhood and adolescence. J Pediatr Orthop 18:328–332PubMedCrossRef
17.
Zurück zum Zitat Huylebroek JF, Martens M, Simon JP (1985) Transchondral talar dome fracture. Arch Orthop Trauma Surg 104:238–241PubMedCrossRef Huylebroek JF, Martens M, Simon JP (1985) Transchondral talar dome fracture. Arch Orthop Trauma Surg 104:238–241PubMedCrossRef
18.
Zurück zum Zitat Ibáñez M, Calvo AB, Alvarez V, Lépore S (2015) Osteochondral lesions of the talus: clinical and functional assessment of conservative vs scope treatment. Orthop J Sports Med 2:2325967114S2325900247 Ibáñez M, Calvo AB, Alvarez V, Lépore S (2015) Osteochondral lesions of the talus: clinical and functional assessment of conservative vs scope treatment. Orthop J Sports Med 2:2325967114S2325900247
19.
Zurück zum Zitat Kitaoka HB, Alexander IJ, Adelaar RS, Nunley JA, Myerson MS, Sanders M (1994) Clinical rating systems for the ankle-hindfoot, midfoot, hallux, and lesser toes. Foot Ankle Int 15:349–353PubMedCrossRef Kitaoka HB, Alexander IJ, Adelaar RS, Nunley JA, Myerson MS, Sanders M (1994) Clinical rating systems for the ankle-hindfoot, midfoot, hallux, and lesser toes. Foot Ankle Int 15:349–353PubMedCrossRef
20.
Zurück zum Zitat Klammer G, Maquieira GJ, Spahn S, Vigfusson V, Zanetti M, Espinosa N (2015) Natural history of nonoperatively treated osteochondral lesions of the talus. Foot Ankle Int 36:24–31PubMedCrossRef Klammer G, Maquieira GJ, Spahn S, Vigfusson V, Zanetti M, Espinosa N (2015) Natural history of nonoperatively treated osteochondral lesions of the talus. Foot Ankle Int 36:24–31PubMedCrossRef
21.
Zurück zum Zitat Lam KY, Siow HM (2012) Conservative treatment for juvenile osteochondritis dissecans of the talus. J Orthop Surg 20:176–180CrossRef Lam KY, Siow HM (2012) Conservative treatment for juvenile osteochondritis dissecans of the talus. J Orthop Surg 20:176–180CrossRef
22.
Zurück zum Zitat Letts M, Davidson D, Ahmer A (2003) Osteochondritis dissecans of the talus in children. J Pediatr Orthop 23:617–625PubMedCrossRef Letts M, Davidson D, Ahmer A (2003) Osteochondritis dissecans of the talus in children. J Pediatr Orthop 23:617–625PubMedCrossRef
23.
Zurück zum Zitat Liu H, Guo H, Guo S, Wang J, Ye Y, Ma C (2019) Novel treatment of 99Tc-MDP improves clinical and radiographic results for patients with osteochondral lesions of the talus. Q J Nucl Med Mol Imaging 63:199–206PubMedCrossRef Liu H, Guo H, Guo S, Wang J, Ye Y, Ma C (2019) Novel treatment of 99Tc-MDP improves clinical and radiographic results for patients with osteochondral lesions of the talus. Q J Nucl Med Mol Imaging 63:199–206PubMedCrossRef
24.
Zurück zum Zitat Dig M, Fusco A, Vetro A, Iosa M, Mantia F, Iovane A et al (2016) Clinical effects of image-guided hyaluronate injections for the osteochondral lesions of ankle in sport active population. J Sports Med Phys Fitness 56:1339–1345 Dig M, Fusco A, Vetro A, Iosa M, Mantia F, Iovane A et al (2016) Clinical effects of image-guided hyaluronate injections for the osteochondral lesions of ankle in sport active population. J Sports Med Phys Fitness 56:1339–1345
25.
Zurück zum Zitat Martijn HA, Lambers KTA, Dahmen J, Stufkens SAS, Kerkhoffs G (2021) High incidence of (osteo)chondral lesions in ankle fractures. Knee Surg Sports Traumatol Arthrosc 29:1523–1534PubMedCrossRef Martijn HA, Lambers KTA, Dahmen J, Stufkens SAS, Kerkhoffs G (2021) High incidence of (osteo)chondral lesions in ankle fractures. Knee Surg Sports Traumatol Arthrosc 29:1523–1534PubMedCrossRef
26.
Zurück zum Zitat McCullough CJ, Venugopal V (1979) Osteochondritis dissecans of the talus: the natural history. Clin Orthop Relat Res 264–268 McCullough CJ, Venugopal V (1979) Osteochondritis dissecans of the talus: the natural history. Clin Orthop Relat Res 264–268
27.
Zurück zum Zitat Meftah M, Katchis SD, Scharf SC, Mintz DN, Klein DA, Weiner LS (2011) SPECT/CT in the management of osteochondral lesions of the talus. Foot Ankle Int 32:233–238PubMedCrossRef Meftah M, Katchis SD, Scharf SC, Mintz DN, Klein DA, Weiner LS (2011) SPECT/CT in the management of osteochondral lesions of the talus. Foot Ankle Int 32:233–238PubMedCrossRef
28.
Zurück zum Zitat Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M (2012) Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med 40:534–541PubMedCrossRef Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M (2012) Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med 40:534–541PubMedCrossRef
29.
Zurück zum Zitat Perumal V, Wall E, Babekir N (2007) Juvenile osteochondritis dissecans of the talus. J Pediatr Orthop 27:821–825PubMedCrossRef Perumal V, Wall E, Babekir N (2007) Juvenile osteochondritis dissecans of the talus. J Pediatr Orthop 27:821–825PubMedCrossRef
30.
Zurück zum Zitat Pettine KA, Morrey BF (1987) Osteochondral fractures of the talus. A long-term follow-up. J Bone Joint Surg Br 69:89–92PubMedCrossRef Pettine KA, Morrey BF (1987) Osteochondral fractures of the talus. A long-term follow-up. J Bone Joint Surg Br 69:89–92PubMedCrossRef
31.
Zurück zum Zitat Ray RB, Coughlin EJ Jr (1947) Osteochondritis dissecans of the talus. J Bone Joint Surg Am 29:697–706PubMed Ray RB, Coughlin EJ Jr (1947) Osteochondritis dissecans of the talus. J Bone Joint Surg Am 29:697–706PubMed
32.
Zurück zum Zitat Rehnitz C, Kuni B, Wuennemann F, Chloridis D, Kirwadi A, Burkholder I et al (2017) Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) and T2 mapping of talar osteochondral lesions: Indicators of clinical outcomes. J Magn Reson Imaging 46:1601–1610PubMedCrossRef Rehnitz C, Kuni B, Wuennemann F, Chloridis D, Kirwadi A, Burkholder I et al (2017) Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) and T2 mapping of talar osteochondral lesions: Indicators of clinical outcomes. J Magn Reson Imaging 46:1601–1610PubMedCrossRef
33.
Zurück zum Zitat Reilingh ML, Kerkhoffs GM, Telkamp CJ, Struijs PA, van Dijk CN (2014) Treatment of osteochondral defects of the talus in children. Knee Surg Sports Traumatol Arthrosc 22:2243–2249PubMedCrossRef Reilingh ML, Kerkhoffs GM, Telkamp CJ, Struijs PA, van Dijk CN (2014) Treatment of osteochondral defects of the talus in children. Knee Surg Sports Traumatol Arthrosc 22:2243–2249PubMedCrossRef
34.
Zurück zum Zitat Roden S, Tillegard P, Unanderscharin L (1953) Osteochondritis dissecans and similar lesions of the talus: report of fifty-five cases with special reference to etiology and treatment. Acta Orthop Scand 23:51–66PubMedCrossRef Roden S, Tillegard P, Unanderscharin L (1953) Osteochondritis dissecans and similar lesions of the talus: report of fifty-five cases with special reference to etiology and treatment. Acta Orthop Scand 23:51–66PubMedCrossRef
36.
Zurück zum Zitat Shearer C, Loomer R, Clement D (2002) Nonoperatively managed stage 5 osteochondral talar lesions. Foot Ankle Int 23:651–654PubMedCrossRef Shearer C, Loomer R, Clement D (2002) Nonoperatively managed stage 5 osteochondral talar lesions. Foot Ankle Int 23:651–654PubMedCrossRef
37.
Zurück zum Zitat Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73:712–716PubMedCrossRef Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73:712–716PubMedCrossRef
38.
Zurück zum Zitat Strauss E, Schachter A, Frenkel S, Rosen J (2009) The efficacy of intra-articular hyaluronan injection after the microfracture technique for the treatment of articular cartilage lesions. Am J Sports Med 37:720–726PubMedCrossRef Strauss E, Schachter A, Frenkel S, Rosen J (2009) The efficacy of intra-articular hyaluronan injection after the microfracture technique for the treatment of articular cartilage lesions. Am J Sports Med 37:720–726PubMedCrossRef
39.
Zurück zum Zitat Thiele S, Thiele R, Gerdesmeyer L (2015) Adult osteochondritis dissecans and focussed ESWT: A successful treatment option. Int J Surg 24:191–194PubMedCrossRef Thiele S, Thiele R, Gerdesmeyer L (2015) Adult osteochondritis dissecans and focussed ESWT: A successful treatment option. Int J Surg 24:191–194PubMedCrossRef
40.
Zurück zum Zitat Thompson JP, Loomer RL (1984) Osteochondral lesions of the talus in a sports medicine clinic: a new radiographic technique and surgical approach. Am J Sports Med 12:460–463PubMedCrossRef Thompson JP, Loomer RL (1984) Osteochondral lesions of the talus in a sports medicine clinic: a new radiographic technique and surgical approach. Am J Sports Med 12:460–463PubMedCrossRef
41.
Zurück zum Zitat van Dijk CN, Verhagen RA, Tol JL (1997) Arthroscopy for problems after ankle fracture. J Bone Joint Surg Br 79:280–284PubMedCrossRef van Dijk CN, Verhagen RA, Tol JL (1997) Arthroscopy for problems after ankle fracture. J Bone Joint Surg Br 79:280–284PubMedCrossRef
42.
Zurück zum Zitat Weigelt L, Laux CJ, Urbanschitz L, Espinosa N, Klammer G, Gotschi T et al (2020) Long-term prognosis after successful nonoperative treatment of osteochondral lesions of the talus: an observational 14-year follow-up study. Orthop J Sports Med 8:2325967120924183PubMedPubMedCentralCrossRef Weigelt L, Laux CJ, Urbanschitz L, Espinosa N, Klammer G, Gotschi T et al (2020) Long-term prognosis after successful nonoperative treatment of osteochondral lesions of the talus: an observational 14-year follow-up study. Orthop J Sports Med 8:2325967120924183PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Wester JU, Jensen IE, Rasmussen F, Lindequist S, Schantz K (1994) Osteochondral lesions of the talar dome in children. A 24 (7–36) year follow-up of 13 cases. Acta Orthop Scand 65:110–112PubMedCrossRef Wester JU, Jensen IE, Rasmussen F, Lindequist S, Schantz K (1994) Osteochondral lesions of the talar dome in children. A 24 (7–36) year follow-up of 13 cases. Acta Orthop Scand 65:110–112PubMedCrossRef
44.
Zurück zum Zitat Zengerink M, Struijs PA, Tol JL, van Dijk CN (2010) Treatment of osteochondral lesions of the talus: a systematic review. Knee Surg Sports Traumatol Arthrosc 18:238–246PubMedCrossRef Zengerink M, Struijs PA, Tol JL, van Dijk CN (2010) Treatment of osteochondral lesions of the talus: a systematic review. Knee Surg Sports Traumatol Arthrosc 18:238–246PubMedCrossRef
45.
Zurück zum Zitat Zinman C, Wolfson N, Reis ND (1988) Osteochondritis dissecans of the dome of the talus. Computed tomography scanning in diagnosis and follow-up. J Bone Joint Surg Am 70:1017–1019PubMedCrossRef Zinman C, Wolfson N, Reis ND (1988) Osteochondritis dissecans of the dome of the talus. Computed tomography scanning in diagnosis and follow-up. J Bone Joint Surg Am 70:1017–1019PubMedCrossRef
Metadaten
Titel
Non-operative management for osteochondral lesions of the talus: a systematic review of treatment modalities, clinical- and radiological outcomes
verfasst von
Tristan M. F. Buck
Kenny Lauf
Jari Dahmen
J. Nienke Altink
Sjoerd A. S. Stufkens
Gino M. M. J. Kerkhoffs
Publikationsdatum
16.04.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Knee Surgery, Sports Traumatology, Arthroscopy / Ausgabe 8/2023
Print ISSN: 0942-2056
Elektronische ISSN: 1433-7347
DOI
https://doi.org/10.1007/s00167-023-07408-w

Weitere Artikel der Ausgabe 8/2023

Knee Surgery, Sports Traumatology, Arthroscopy 8/2023 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

TEP mit Roboterhilfe führt nicht zu größerer Zufriedenheit

15.05.2024 Knie-TEP Nachrichten

Der Einsatz von Operationsrobotern für den Einbau von Totalendoprothesen des Kniegelenks hat die Präzision der Eingriffe erhöht. Für die postoperative Zufriedenheit der Patienten scheint das aber unerheblich zu sein, wie eine Studie zeigt.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.